Dimensional Fund Advisors
LENZ

Dimensional Fund Advisors’s LENZ Therapeutics LENZ Stock Holding History

Dimensional Fund Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Sell
24,892
-16,982
-41% -$137K ﹤0.01% 3110
2026
Q1 		$381K Sell
41,874
-71,220
-63% -$1M ﹤0.01% 2981
2025
Q4 		$1.81M Buy
113,094
+72,208
+177% +$2.1M ﹤0.01% 2753
2025
Q3 		$1.9M Hold
40,886
– – ﹤0.01% 2774
2025
Q2 		$1.2M Sell
40,886
-895
-2% -$24.3K ﹤0.01% 2860
2025
Q1 		$1.07M Buy
41,781
+7,762
+23% +$191K ﹤0.01% 2868
2024
Q4 		$983K Sell
34,019
-154
-0.5% -$4.69K ﹤0.01% 2918
2024
Q3 		$812K Sell
34,173
-3,017
-8% -$67K ﹤0.01% 2943
2024
Q2 		$644K Buy
37,190
+13,653
+58% +$238K ﹤0.01% 2986
2024
Q1 		$526K Buy
23,537
+7,038
+43% +$146K ﹤0.01% 3034
2023
Q4 		$303K Buy
16,499
+1,918
+13% +$31.7K ﹤0.01% 3134
2023
Q3 		$253K Sell
14,581
-444
-3% -$7.72K ﹤0.01% 3177
2023
Q2 		$273K Buy
15,025
+7,631
+103% +$152K ﹤0.01% 3182
2023
Q1 		$127K Buy
+7,394
New +$120K ﹤0.01% 3275
2022
Q3 		$34K Buy
+1,522
New +$36.3K ﹤0.01% 3439

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Dimensional Fund Advisors's LENZ Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its LENZ Therapeutics (LENZ) stake by 41% in Q2 2026, selling an estimated $137K and leaving 24,892 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #3110.

Dimensional Fund Advisors first reported a position in LENZ in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.9M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Dimensional Fund Advisors held 24,892 shares of LENZ Therapeutics worth $142K as of Q2 2026.
  • Dimensional Fund Advisors sold 16,982 LENZ Therapeutics shares in Q2 2026, an estimated $137K.
  • LENZ Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3110 holding.
  • Dimensional Fund Advisors first reported a position in LENZ Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's LENZ Therapeutics position peaked at $1.9M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.